|Articles|July 1, 2012
- BioPharm International-07-01-2012
- Volume 25
- Issue 7
BioPharm International, July 2012 Issue (PDF)
A New Era in Cell Culture Media Development
Advertisement
Articles in this issue
over 13 years ago
A 25-Year Retrospective on Bio-Engineeringover 13 years ago
Biomanufacturing Innovationover 13 years ago
Pharmaceutical Dealmaking Broadens its Partnering Baseover 13 years ago
Reduce Analytical Testing and Costs Without Compromising Complianceover 13 years ago
The Truth About Drug Shortagesover 13 years ago
Allogeneic Versus Autologous Stem-Cell Therapyover 13 years ago
Optimizing Expression Systemsover 13 years ago
Considerations for Successful Upstream Process Developmentover 13 years ago
A New Era in Cell Culture Media DevelopmentNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
